Literature DB >> 17682974

Alpha1-antitrypsin deficiency in childhood.

Jeffrey H Teckman1.   

Abstract

Alpha (1)-antitrypsin deficiency is a common genetic disease in which individuals homozygous for the mutant Z allele are at risk for the development of liver disease and emphysema. The mutant Z protein product is synthesized in hepatocytes but then accumulates intracellularly rather then being appropriately secreted. The effects of the intracellular accumulation of the mutant Z protein in the liver include the formation of protein polymers, activation of autophagy, mitochondrial injury, and caspase activation, which progress in a cascade causing hepatocellular injury. Liver disease can occur at any age, although the majority of children are free of significant liver dysfunction. The variable clinical presentations suggest an important contribution of genetic and environmental disease modifiers. The heterozygous carrier state for the mutant Z gene, present in 1.5% to 3% of the population, is not itself a common cause of liver injury but may be a modifier gene for other liver diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17682974     DOI: 10.1055/s-2007-985072

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  10 in total

1.  Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.

Authors:  Elizabeth M Brunt; Keith Blomenkamp; Muneeb Ahmed; Faiza Ali; Nancy Marcus; Jeffrey Teckman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-11       Impact factor: 2.839

2.  Expanded carrier screening panels-does bigger mean better?

Authors:  Sara Wienke; Kimberly Brown; Meagan Farmer; Charlie Strange
Journal:  J Community Genet       Date:  2013-09-24

Review 3.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

4.  Alpha-1-Antitrypsin Deficiency: An Important Cause of Pediatric Liver Disease.

Authors:  Amy Feldman; Ronald J Sokol
Journal:  Lung Health Prof Mag       Date:  2013

5.  Activating transcription factor 6 limits intracellular accumulation of mutant α(1)-antitrypsin Z and mitochondrial damage in hepatoma cells.

Authors:  Steven E Smith; Susana Granell; Laia Salcedo-Sicilia; Giovanna Baldini; Gustavo Egea; Jeff H Teckman; Giulia Baldini
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

6.  Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model.

Authors:  Shalesh Kaushal; Mani Annamali; Keith Blomenkamp; David Rudnick; Donna Halloran; Elizabeth M Brunt; Jeffrey H Teckman
Journal:  Exp Biol Med (Maywood)       Date:  2010-06

7.  Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension.

Authors:  Jeffrey H Teckman; Philip Rosenthal; Robert Abel; Lee M Bass; Sonia Michail; Karen F Murray; David A Rudnick; Daniel W Thomas; Cathie Spino; Ronen Arnon; Paula M Hertel; James Heubi; Binita M Kamath; Wikrom Karnsakul; Kathleen M Loomes; John C Magee; Jean P Molleston; Rene Romero; Benjamin L Shneider; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

8.  Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension.

Authors:  Jeffrey Teckman; Philip Rosenthal; Kieran Hawthorne; Cathie Spino; Lee M Bass; Karen F Murray; Nanda Kerkar; John C Magee; Saul Karpen; James E Heubi; Jean P Molleston; Robert H Squires; Binita M Kamath; Stephen L Guthery; Kathleen M Loomes; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr       Date:  2020-07-11       Impact factor: 6.314

9.  Appropriateness of newborn screening for α1-antitrypsin deficiency.

Authors:  Jeffrey Teckman; Erin Pardee; R Rodney Howell; David Mannino; Richard R Sharp; Mark Brantly; Adam Wanner; Jamie Lamson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-02       Impact factor: 2.839

10.  Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency.

Authors:  Shujuan Pan; Lu Huang; John McPherson; Donna Muzny; Farshid Rouhani; Mark Brantly; Richard Gibbs; Richard N Sifers
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.